Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Rognli EB, Andersen KAA, Aas EM, Reme SE, Lystad JU, Stavseth MR, Arnevik EA(2025) The effectiveness of Individual Placement and Support on vocational outcomes for patients with substance use disorders: A pragmatic superiority randomized controlled trial of Individual Placement and Support versus enhanced self-help Addiction(in press) DOI 10.1111/add.70155, PubMed 40702951
Lunde P, Bye A, Grimsmo J, Pripp AH, Ritschel V, Jarstad E, Nilsson BB(2025) Authors' Reply: The Transtheoretical Model: Is It Still the Best We Have? J Med Internet Res, 27, e79131 DOI 10.2196/79131, PubMed 40698751
Tengesdal S, Molberg Ø, Holme Ø, Gran JT, Myklebust G(2025) Mortality in polymyalgia rheumatica: a 38-year prospective population-based cohort study from Southern Norway Arthritis Res Ther, 27(1), 154 DOI 10.1186/s13075-025-03613-9, PubMed 40691638